[Cerebral infarct in a patient with diabetes mellitus].
Mora
C
C
Macía
M
M
García
J
J
Navarro
J F
JF
D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use; D001037:Aphasia / Q000209:etiology; D001925:Brain Damage, Chronic / Q000209:etiology; D003922:Diabetes Mellitus, Type 1 / Q000150:complications*; D003928:Diabetic Nephropathies / Q000150:complications*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D020244:Infarction, Middle Cerebral Artery / Q000209:etiology*; D008297:Male; D017762:Nadroparin / Q000627:therapeutic use; D009404:Nephrotic Syndrome / Q000150:complications*; D010291:Paresis / Q000209:etiology; D012907:Smoking / Q000009:adverse effects; D013923:Thromboembolism / Q000517:prevention & control
D000925:Anticoagulants; D017762:Nadroparin; D006493:Heparin